Tomas Lamas

Dr. Tomas Lamas

Centro Hospitalar de Lisboa Ocidental
+1
orcid

Research Focus & Metrics

Academic Career Length

20Years (2007-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
22 March 2021 in Membranes
Verified
Journal Article
Open access
PDF file
BFBarbara Ficial
Barbara Ficial
FVFrancesco Vasques
Francesco Vasques
JZJoe Zhang
Joe Zhang
SWStephen Whebell
Stephen Whebell
MSMichael Slattery
Michael Slattery
LCLuigi Camporota
Luigi Camporota
Extracorporeal life support (ECLS) for severe respiratory failure has seen an exponential growth in recent years. Extracorporeal membrane oxygenation (ECMO) and extracorporeal CO2 removal (ECCO2R) represent two modalities that can provide full or partial support of the native lung function, when mechanical ventilation is either unable to achieve sufficient gas exchange to meet metabolic demands, or when its intensity is considered injurious. While the use of ECMO has defined indications in clinical practice, ECCO2R remains a promising technique, whose safety and efficacy are still being investigated. Understanding the physiological principles of gas exchange during respiratory ECLS and the interactions with native gas exchange and haemodynamics are essential for the safe applications of these techniques in clinical practice. In this review, we will present the physiological basis of gas exchange in ECMO and ECCO2R, and the implications of their interaction with native lung function. We will also discuss the rationale for their use in clinical practice, their current advances, and future directions.

3 October 2024 in Anaesthesia Critical Care & Pain Medicine
Verified
Journal Article
Open access
Filipe André GonzalezFilipe André Gonzalez
Filipe André Gonzalez
CSCristina Santonocito
Cristina Santonocito
TLTomas Lamas
Tomas Lamas
PCPedro Gaspar da Costa
Pedro Gaspar da Costa
Susana VieiraSusana Vieira
Susana Vieira
Filippo SanfilippoFilippo Sanfilippo
Filippo Sanfilippo
Integrating machine learning (ML) into intensive care units (ICUs) can significantly enhance patient care and operational efficiency. ML algorithms can analyze vast amounts of data from electronic health records, physiological monitoring systems, and other medical devices, providing real-time insights and predictive analytics to assist clinicians in decision-making. ML has shown promising results in predictive modeling for patient outcomes, early detection of sepsis, optimizing ventilator settings, and resource allocation. For instance, predictive algorithms have demonstrated high accuracy in forecasting patient deterioration, enabling timely interventions and reducing mortality rates. Despite these advancements, challenges such as data heterogeneity, integration with existing clinical workflows, and the need for transparency and interpretability of ML models persist. The deployment of ML in ICUs also raises ethical and legal considerations regarding patient privacy and the potential for algorithmic biases. For clinicians interested in the early embracing of AI-driven changes in clinical practice, in this review, we discuss the challenges of integrating AI and ML tools in the ICU environment in several steps and issues: 1. Main categories of ML algorithms; 2. From data enabling to ML development; 3. Decision-support systems that will allow patient stratification, accelerating the foresight of adequate individual care; 4. Improving patient outcomes and healthcare efficiency, with positive society and research implications; 5. Risks and barriers to AI-ML application to the healthcare system, including transparency, privacy, and ethical concerns.

24 December 2024 in Journal of Clinical Medicine
Verified
Journal Article
Open access
PDF file
TLTomas Lamas
Tomas Lamas
SFSusana Mendes Fernandes
Susana Mendes Fernandes
FVFrancesco Vasques
Francesco Vasques
CKChristian Karagiannidis
Christian Karagiannidis
LCLuigi Camporota
Luigi Camporota
NBNicholas Barrett
Nicholas Barrett
Extracorporeal carbon dioxide removal (ECCO2R) is an emerging technique designed to reduce carbon dioxide (CO2) levels in venous blood while enabling lung-protective ventilation or alleviating the work of breathing. Unlike high-flow extracorporeal membrane oxygenation (ECMO), ECCO2R operates at lower blood flows (0.4–1.5 L/min), making it less invasive, with smaller cannulas and simpler devices. Despite encouraging results in controlling respiratory acidosis, its broader adoption is hindered by complications, including haemolysis, thrombosis, and bleeding. Technological advances, including enhanced membrane design, gas exchange efficiency, and anticoagulation strategies, are essential to improving safety and efficacy. Innovations such as wearable prototypes that adapt CO2 removal to patient activity and catheter-based systems for lower blood flow are expanding the potential applications of ECCO2R, including as a bridge-to-lung transplantation and in outpatient settings. Promising experimental approaches include respiratory dialysis, carbonic anhydrase-coated membranes, and electrodialysis to maximise CO2 removal. Further research is needed to optimise device performance, develop cost-effective systems, and establish standardised protocols for safe clinical implementation. As the technology matures, integration with artificial intelligence (AI) and machine learning may personalise therapy, improving outcomes. Ongoing clinical trials will be pivotal in addressing these challenges, ultimately enhancing the role of ECCO2R in critical care and its accessibility across healthcare settings.

20 September 2007 in Physical Review Letters
Verified
Journal Article
Closed access
PDF file
GGGennady M. Gusev
Gennady M. Gusev
ABA. K. Bakarov
A. K. Bakarov
TLTomas Lamas
Tomas Lamas
JPJ. C. Portal
J. C. Portal
We report on the measurements of the quantum Hall effect states in double quantum well structures at the filling factors ν=4N+1 and ν=4N+3, where N is the Landau index number, in the presence of the in-plane magnetic field. The quantum Hall states at these filling factors vanish and reappear several times and exhibit anisotropy. Repeated reentrance of the transport gap occurs due to the periodic vanishing of the tunneling amplitude in the presence of the in-plane field. Anisotropy demonstrates the existence of the stripes in the ground states.

1 July 2019 in Open Access Emergency Medicine
Verified
Journal Article
Open access
PDF file
JTJoão Galaz Tavares
João Galaz Tavares
RIRita Ivo
Rita Ivo
Filipe André GonzalezFilipe André Gonzalez
Filipe André Gonzalez
TLTomas Lamas
Tomas Lamas
JMJoão João Mendes
João João Mendes
Ultrasound technology is an essential tool in the management of critically ill patients. Point-of-care ultrasonography (POCUS) enables data collection from different anatomic areas to achieve the most probable diagnosis and administer the right therapy at the right time. Despite the increasing utilization of POCUS, there is still a lack of standards to establish how to use different bedside ultrasound protocols, and it is imperative to develop a unifying protocol. Thus, the aim of this paper is to establish a new systematized approach that can be adopted by all physicians to implement POCUS for critically ill patient management. To achieve this, we propose a new systematized approach—Global Ultrasound Check for the Critically Ill (GUCCI)—that integrates multiple protocols. This protocol is organized based on three syndromes (acute respiratory failure, shock, and cardiac arrest) and includes ultrasound-guided procedures.

28 November 2024 in Preprints.org
Verified
Preprint
Open access
PDF file
TLTomas Lamas
Tomas Lamas
SFSusana Mendes Fernandes
Susana Mendes Fernandes
FVFrancesco Vasques
Francesco Vasques
CKChristian Karagiannidis
Christian Karagiannidis
LCLuigi Camporota
Luigi Camporota
NBNicholas Barret
Nicholas Barret
Extracorporeal carbon dioxide removal (ECCO2R) is an emerging technique designed to reduce carbon dioxide (CO2) levels in venous blood while enabling lung-protective ventilation or alleviating the work of breathing. Unlike high-flow extracorporeal membrane oxygenation (ECMO), ECCO2R operates at lower blood flows (0.4–1.5 L/min), making it less invasive, with smaller cannulas and simpler devices. Despite encouraging results in controlling respiratory acidosis, its broader adoption is hindered by complications, including haemolysis, thrombosis, and bleeding. Technological advances, including enhanced membrane design, gas exchange efficiency, and anti-coagulation strategies, are essential to improving safety and efficacy. Innovations such as wearable prototypes that adapt CO2 removal to patient activity and catheter-based systems for lower blood flow are expanding the potential applications of ECCO2R, including as a bridge to lung transplantation and in outpatient settings. Promising experimental approaches include respiratory dialysis, carbonic anhydrase-coated membranes, and electrodialysis to maximise CO2 removal. Further research is needed to optimise device performance, develop cost-effective systems, and establish standardised protocols for safe clinical implementation. As the technology matures, integration with artificial intelligence (AI) and machine learning may personalise therapy, improving outcomes. Ongoing clinical trials will be pivotal in addressing these challenges, ultimately enhancing the role of ECCO2R in critical care and its accessibility across healthcare settings.